Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors
2016 · Cancer Discovery · 742 citations
https://doi.org/10.1158/2159-8290.cd-16-0095
M
Muralidhar Beeram
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
162
Papers
6.8K
Citations
34
h-index
61
i10-index
Muralidhar Beeram is an academic researcher from South Texas Accelerated Research Therapeutics. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & HER2/EGFR in Cancer Research & Advanced Breast Cancer Therapies. The author has an h-index of 34, co-authored 138 publications.
Papers by this author
worksPhase I Study of Trastuzumab-DM1, an HER2 Antibody-Drug Conjugate, Given Every 3 Weeks to Patients With HER2-Positive Metastatic Breast Cancer
2010 · Journal of Clinical Oncology · 591 citations
https://doi.org/10.1200/jco.2009.26.2071
A phase 1 study of weekly dosing of trastuzumab emtansine (T‐DM1) in patients with advanced human epidermal growth factor 2–positive breast cancer
2012 · Cancer · 102 citations
https://doi.org/10.1002/cncr.27622
Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study
2024 · Journal of Clinical Oncology · 31 citations
https://doi.org/10.1200/jco.23.02733
Zanidatamab monotherapy or combined with chemotherapy in HER2-expressing gastroesophageal adenocarcinoma: a phase 1 trial
2025 · Nature Communications · 5 citations
https://doi.org/10.1038/s41467-025-59279-z
Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study
2025 · Frontiers in Oncology · 1 citations
https://doi.org/10.3389/fonc.2025.1555921
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat